Work-related stress linked to poor cardiovascular health

Research shows work-related stress negatively affects cardiovascular health, with implications for health behaviors and outcomes in diverse adult populations.

Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Half Year Results 30-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR

August 31, 2024

Inflammation may not be key to fighting liver fibrosis in MAFLD

Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD),

July 27, 2024

Muvalaplin shows promise in lowering Lp(a) levels in clinical trial

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science

November 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.